Myodenovo develops proprietary, patent-pending plant-based scaffold technology and an automated bioreactor process to produce thick, whole-cut cultivated meats, beginning with filet mignon. The company says its end products will be roughly 90% cells to deliver a realistic meat experience and has built a small, bite-size prototype filet. Founder George Engelmayr is a biomedical engineer with regenerative-medicine experience and prior roles at Memphis Meats (UPSIDE Foods) and Mission Barns. Myodenovo plans to grow a larger medallion for a tasting later this year and aims to raise $2 million in a pre-seed round within the next 18 months. The startup will use initial funding for general corporate expenses and operations as it scales its scaffold and bioreactor processes. The company is based in North Carolina, USA.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2023